GSK Belantamab Mafodotin shows to help blood cancer patients Medical Dialogues Bureau26 Aug 2019 3:45 AM GMTTwo doses of Belantamab Mafodotin helped subdue the disease in adults who had received three prior treatments for multiple myeloma, a cancer of the...
Canada enacts drug price crackdown, in blow to pharmaceutical industry Medical Dialogues Bureau11 Aug 2019 3:30 AM GMTThe changes are the biggest reform to Canada's drug price regime since 1987 and could eventually cut the earnings of drugmakers in the United States,...
Bristol-Myers posts strong second quarter as Eliquis, Orencia sales propel Medical Dialogues Bureau28 July 2019 3:47 AM GMTSales of Eliquis, which Bristol-Myers shares with Pfizer Inc (PFE.N), rose 24% to $2.04 billion, while Orencia sales rose 9% to $778 million, both...
GSK offers concessions to address Pfizer deal concerns Farhat Nasim23 Jun 2019 3:29 AM GMTGSK announced the deal in December last year, a move which will put it ahead of rivals Johnson & Johnson, Bayer and Sanofi.BRUSSELS:...
Merck wins USFDA nod for blockbuster drug Keytruda to treat head, neck cancer Medical Dialogues Bureau12 Jun 2019 4:20 AM GMTThe approval is based on results from a late-stage trial, where Keytruda showed a significant improvement in overall survival in cancer patients,...
Merck, Rigaku partner to develop novel molecular structure analysis technology Farhat Nasim10 Jun 2019 3:45 AM GMTThe partnership creates an outstanding strategic opportunity for both companies, Merck and Rigaku to establish leading products for chemical...
CDSCO releases updated list of 2006 WHO GMP certified drug manufacturers; Details Farhat Nasim6 Jun 2019 6:41 AM GMTNew Delhi: The apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has recently released an updated list of WHO GMP...
Merck wins USFDA approval for Keytruda as combo therapy for kidney cancer Farhat Nasim22 April 2019 4:00 AM GMTNew Delhi: Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (USFDA) has approved...
Merck, Enigma Biomedical signs license agreement for Novel MK 6884 Imaging Agent Garima20 March 2019 4:16 AM GMTAs part of the agreement with Merck, EBG will be responsible for the clinical development and commercialization of MK-6884 in return for payment of...
Currency headwinds quell drug gains in Q4; says Merck KGaA Garima10 March 2019 3:29 AM GMTFRANKFURT: Germany's Merck KGaA posted a 1.3 per cent decline in adjusted core earnings in the fourth quarter as negative currency effects more than...
French court dismisses damage claims against Merck over Levothyrox Farhat Nasim8 March 2019 3:45 AM GMTThe plaintiffs had accused Merck of not providing sufficient information regarding changes to the Levothyrox.France: A court in the French city of...
Merck launches cutting edge fertility technologies in India Farhat Nasim28 Feb 2019 3:35 AM GMTThe introduction of cutting-edge fertility technology complements Merck portfolio and promises to decrease manual labour, increases precision and thus...